The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online
doi:10.1084/jem.20071003
The Journal of Experimental Medicine, Vol. 204, No. 13, 3085-3093
The Rockefeller University Press, 0022-1007 $30.00
© Six et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 3633K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Six, E. M.
Right arrow Articles by André-Schmutz, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Six, E. M.
Right arrow Articles by André-Schmutz, I.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

BRIEF DEFINITIVE REPORT

 A human postnatal lymphoid progenitor capable of circulating and seeding the thymus

Emmanuelle M. Six1,2, Delphine Bonhomme1,2, Marta Monteiro2,3, Kheira Beldjord2,4,7, Monika Jurkowska4, Corinne Cordier-Garcia2, Alexandrine Garrigue1,2,5, Liliane Dal Cortivo5, Benedita Rocha2,3, Alain Fischer1,2,6, Marina Cavazzana-Calvo1,2,5, and Isabelle André-Schmutz1,2

1 Institut National de la Santé et de la Recherche Médicale (INSERM), U768, 75015 Paris, France
2 Faculté de Médecine René Descartes, Institut Federatif de Recherche 94, Université Paris-Descartes, 75015 Paris, France
3 INSERM, U591, 75015 Paris, France
4 Laboratoire d'Hématologie, 5 Département de Biothérapie, and 6 Service d'Immunologie et d'Hématologie Pédiatrique, Hopital Necker-Enfants Malades, Assistance Publique–Hôpitaux de Paris, 75015 Paris, France
7 INSERM, EMI0210, 75015 Paris, France

CORRESPONDENCE Isabelle André-Schmutz: andre-schmutz{at}necker.fr

Identification of a thymus-seeding progenitor originating from human bone marrow (BM) constitutes a key milestone in understanding the mechanisms of T cell development and provides new potential for correcting T cell deficiencies. We report the characterization of a novel lymphoid-restricted subset, which is part of the lineage-negative CD34+CD10+ progenitor population and which is distinct from B cell–committed precursors (in view of the absence of CD24 expression). We demonstrate that these Lin–CD34+CD10+CD24– progenitors have a very low myeloid potential but can generate B, T, and natural killer lymphocytes and coexpress recombination activating gene 1, terminal deoxynucleotide transferase, PAX5, interleukin 7 receptor {alpha}, and CD3{epsilon}. These progenitors are present in the cord blood and in the BM but can also be found in the blood throughout life. Moreover, they belong to the most immature thymocyte population. Collectively, these findings unravel the existence of a postnatal lymphoid-polarized population that is capable of migrating from the BM to the thymus.

E.M. Six and D. Bonhomme contributed equally to this work.

D. Bonhomme's present address is Cythéris, 92130 Issy-les-Moulineaux, France.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS